Previous 10 | Next 10 |
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it has been invited to present a corporate overview at the H.C. Wainwright 24 th Annual Global Inve...
Summary Treatments such as Aricept and likely simufilam that inhibit the formation of the nitro-oxidant peroxynitrite and speed its decomposition stabilize Alzheimer's disease for about a year. Treatments (blarcamesine, Trappsol Cyclo, panax ginseng) that inhibit the formation of ...
Summary Multiple insiders have purchased shares on the open market in the last month. The company has now released positive 100 patient 12-month data. Another journal cleared the company of any wrongdoing. The SEC has officially ended any inquiries into the company. ...
Gainers: Curis ( CRIS ) +36% . Allarity Therapeutics ( ALLR ) +23% . Codiak BioSciences ( CDAK ) +21% . Cassava Sciences ( SAVA ) +17% . AlerisLife ( ALR ) +11% . Losers: Blue Water Vaccines ( BWV ) -27% ...
A review by the Journal of Prevention of Alzheimer's Disease has found no evidence of data manipulation in a 2020 paper on Cassava Sciences' ( NASDAQ: SAVA ) Alzheimer's candidate simufilam. "We do not find convincing evidence of manipulation of data or intent to m...
AUSTIN, Texas, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, was recently informed by the Journal of Prevention of Alzheimer's Disease (JPAD) that there is no convincing evidence to ...
Stocks slipped on Wednesday following the release of anemic retail sales statistics, as investors took profits following a recent upswing. With the retreat, the Dow broke a five-session winning streak. Amid the overall decline, semiconductor stocks came under particular pressure. Analog...
Even as market indexes turned lower Wednesday, not all stocks were feeling the pinch. Both the S&P 500 and the Nasdaq Composite were sharply lower, down 1% and 1.5% (as of this writing around 12:30 p.m., ET). Bucking the trend however, were these three stocks that appear to ...
Gainers: Blue Water Vaccines ( BWV ) +108% . Hill International ( HIL ) +61% . Eargo ( EAR ) +58% . JE Cleantech Holdings ( JCSE ) +44% . Cassava Sciences ( SAVA ) +30% . Laird Superfood ( LSF ) +19% . LexinFintec...
Cassava Sciences ( NASDAQ: SAVA ) is having its best day in months as shares are up 39% in Wednesday morning trading. Shares got a boost after Tuesday's closing bell when an SEC filing revealed that a company director s ignificantly added to his holding . Even ...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...